Emergent BioSolutions (EBS) director granted RSUs and stock options for board service
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Emergent BioSolutions Inc. director John D. Fowler Jr. received equity compensation for Board and Committee service. He was granted 25,344 restricted stock units (RSUs), each representing one share of common stock that will vest on the day prior to the one-year anniversary of the grant date, as long as he remains on the board through that date. He was also granted 11,296 stock options to buy common shares at an exercise price of $7.99 per share, expiring on April 30, 2033, which vest on the same one-year schedule. Following the RSU grant, his direct common stock holdings increased to 30,350 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
FOWLER JOHN D JR
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 11,296 | $0.00 | -- |
| Grant/Award | Common Stock | 25,344 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 11,296 shares (Direct, null);
Common Stock — 30,350 shares (Direct, null)
Footnotes (1)
- Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
Key Figures
RSUs granted: 25,344 RSUs
Options granted: 11,296 options
Option exercise price: $7.99 per share
+3 more
6 metrics
RSUs granted
25,344 RSUs
Annual equity grant for Board and Committee service on April 30, 2026
Options granted
11,296 options
Stock options granted for Board and Committee service on April 30, 2026
Option exercise price
$7.99 per share
Exercise price for 11,296 stock options granted
Option expiration
April 30, 2033
Expiration date of granted stock options
Shares held after grant
30,350 shares
Director’s direct common stock holdings following RSU grant
Vesting period
1 year from grant
RSUs and options vest day prior to one-year anniversary of grant date
Key Terms
restricted stock units ("RSUs"), Stock Incentive Plan, Black-Scholes value, Annual Grant Vesting Date, +1 more
5 terms
restricted stock units ("RSUs") financial
"Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Incentive Plan financial
"granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
Black-Scholes value financial
"dividing by the Black-Scholes value of a single option calculated as of the date of the grant"
Annual Grant Vesting Date financial
"will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date")"
stock options financial
"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
What did Emergent BioSolutions (EBS) director John D. Fowler Jr. receive in this Form 4?
Director John D. Fowler Jr. received equity compensation, including 25,344 restricted stock units and 11,296 stock options. These awards were granted for Board and Committee service under Emergent BioSolutions’ stock incentive plan, instead of being open-market share purchases.
How many Emergent BioSolutions (EBS) RSUs were granted to the director and when do they vest?
He was granted 25,344 restricted stock units. Each RSU converts into one share of common stock. The RSUs vest on the day before the one-year anniversary of the April 30, 2026 grant date, assuming he remains a member of the board through that vesting date.
What stock options did John D. Fowler Jr. receive from Emergent BioSolutions (EBS)?
He received 11,296 stock options, each allowing the purchase of one share of common stock at an exercise price of $7.99. These options vest on the same one-year schedule and expire on April 30, 2033, if not exercised earlier.
How was the number of Emergent BioSolutions (EBS) stock options granted to the director determined?
The number of options was calculated by taking 25% of the total non-employee director compensation value and dividing it by the Black-Scholes value of a single option. That formula produced the 11,296 options reported in the Form 4 footnotes.
Are the Emergent BioSolutions (EBS) equity awards to the director tied to continued board service?
Yes. Both the RSUs and stock options vest on the day before the one-year anniversary of the grant date, only if John D. Fowler Jr. continues serving on Emergent BioSolutions’ board of directors through that Annual Grant Vesting Date.